Ally (cataract system)

2022: Device Announcement

On August 16, 2022, Lensar announced the first commercial operations using Ally's adaptive cataract treatment system. The company said it plans to install eight to 12 Ally systems in 2022.

The laser independently forms a corneal incision, circular capsulorexis and crushes the lens. Peculiarity of femtosecond cataract removal operation by laser is destruction of clouded lens through cornea. The laser beam focuses in the thickness of the lens without damaging the cornea. After a powerful short-term exposure, the clouded lens splits into tiny particles. The surgeon does not need to introduce surgical instruments into the eye, thus reducing the risk of postoperative complications for the patient.

Cataract Laser Treatment System Entered the Market

The first procedures were performed by Dr. Robert Weinstock at the West Florida Eye Institute, where he performed 15 laser-assisted cataract surgeries following the recent installation of the Ally system. The system was approved by the U.S. Department of Health in June 2022 and was developed by Lensar to facilitate the entire cataract surgery procedure in a single, sterile setting to reduce overall time and improve patient and surgeon experiences.

Lensar partners with cataract surgeons and surgical centers to integrate the Ally system. The functions of the system are designed to enable surgeons to improve clinical outcomes. According to company representatives, it has augmented reality and cataract density imaging functions, which gives surgeons a new level of guidance and confidence when performing surgery.

According to Lensar CEO Nick Curtis, Lensar's first-generation LLS systems performed 99.7% uptime and the company is committed to making sure the Ally system beats those numbers. Overall, our goal is to exceed the expectations of surgeons, staff and patients across all performance measures. As Ally enters the market at a time when first-generation femtosecond lasers are significantly obsolete, the system provides surgeons with the ability to continue performing cataract laser surgery with a robust next-generation platform.^[1]

Notes